|
Industry Praises PMA Acceptance Draft Guidance, With Some Reservations
The FDA’s draft guidance on the PMA acceptance process follows transparency and time goals outlined during recent FDA-industry Medical Device User Fee Act (MDUFA) negotiations and provides details that will help ensure a smooth and productive review, industry comments suggest.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives